Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III long-term ulipristal study in uterine myoma
jRCT2080223681Phase 3Completed
- Sponsor
- ASKA Pharmaceutical Holdings Co., Ltd.
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ulipristal in Fibromyoma (LM), sponsored by ASKA Pharmaceutical Holdings Co., Ltd. Started Oct 2017; status: completed.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on jRCT2080223681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223681.